Announcements

    Drinks

      Instrument data
      Senority
      Senior Unsecured
      Currency
      HUF
      ISIN
      HU0000360441
      Coupon percent
      1.75%
      Coupon type
      Fixed
      Instrument volume
      70,000,000,000
      Maturity date
      04/06/2031
      -
      BBB+ Outlook: None
      BBB+ Outlook: None
      Latest change
      Affirmed
      23/04/2024
      General information
      Rating
      Public
      Solicited
      With issuer participation
      UK endorsed
      EU Rated
      Azza Chammem Lead analyst
      Philipp Wass Committee chair
      Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon

      23/4/2024 Rating announcement EN

      Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon

      The affirmation mainly reflects the still very strong financial risk profile as well as the good prospects for growth and cash generation despite macroeconomic challenges and geopolitical uncertainties.

      Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon

      26/4/2023 Rating announcement EN

      Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon

      The affirmation mainly reflects the still strong financial risk profile as well as the good prospects for growth and cash generation despite macroeconomic and geopolitical challenges.

      Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon

      3/5/2022 Rating announcement EN

      Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon

      The affirmation mainly reflects a continued strong financial risk profile as well as good prospects for growth and cash generation despite potential disruption from the Russian and Ukrainian business.

      Scope assigns first-time issuer rating of BBB+/Stable to Hungarian pharma Gedeon Richter

      26/5/2021 Rating announcement EN

      Scope assigns first-time issuer rating of BBB+/Stable to Hungarian pharma Gedeon Richter

      The issuer credit rating mainly reflects the strong financial risk profile, solid competitive position in speciality innovative and generic pharmaceuticals, and good prospects for growth and cash generation.

      Date Title